EnhancedTRAIL protein (DYKDDDDK Tag)

Produktnummer ABIN1305228

Dieses Recombinant -Protein wird in Escherichia coli (E. coli) exprimiert und wurde in 5+ Publikationen erwähnt.

Kurzübersicht für EnhancedTRAIL protein (DYKDDDDK Tag) (ABIN1305228)

Target: EnhancedTRAIL

Protein-Typ: Recombinant

Spezies: Human, Maus

Quelle: Escherichia coli (E. coli)

Applikation: Biochemical Assay (BCA), SDS-PAGE (SDS)

Produktdetails

Aufreinigungstag / Konjugat: DYKDDDDK Tag

Spezifität: Binds to human and mouse TRAIL receptors and human osteoprotegrin (OPG).

Kreuzreaktivität: Human, Maus

Bestandteile: 1 Set: 2x10μg TRAIL, Soluble (human) (rec.)3x50μg TNF Ligands Enhancer (

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Kommentare:

Source/Host: Produced in E. coli. A FLAG®-tag is fused at the N-terminus of the extracellular domain of human TRAIL (aa 95-281).Concentration: TRAIL: 0.1mg/ml after reconstitutionTNF Ligands Enhancer: 1mg/ml after reconstitutionPurity: >95% (SDS-PAGE)Formulation:Lyophilized. Contains PBS.Endotoxin Content:TRAIL: <0.01EU/μg purified protein (LAL test, Lonza).TNF Ligands Enhancer: <0.01EU/μg purified protein (LAL test, Lonza).Reconstitution:TRAIL: reconstitute with 100μl sterile water. PBS containing at least 0.1% BSA should be used for further dilutions.TNF Ligands Enhancer: reconstitute each vial with 50μl sterile water. PBS containing at least 0.1% BSA should be used for further dilutions.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: Lot specific

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Short Term Storage: +4°C
Long Term Storage: -20°C
Stable for at least 6 months after receipt when stored at -20°C.

Haltbarkeit: 6 months

Referenzen

Xiao, Yang, Asadi, Beguinot, Hao: "Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/PEA-15 in glioma cells." in: The Journal of biological chemistry, Vol. 277, Issue 28, pp. 25020-5, (2002) (PubMed).

Déjosez, Ramp, Mahotka, Krieg, Walczak, Gabbert, Gerharz: "Sensitivity to TRAIL/APO-2L-mediated apoptosis in human renal cell carcinomas and its enhancement by topotecan." in: Cell death and differentiation, Vol. 7, Issue 11, pp. 1127-36, (2001) (PubMed).

Benedict, Norris, Prigozy, Bodmer, Mahr, Garnett, Martinon, Tschopp, Gooding, Ware: "Three adenovirus E3 proteins cooperate to evade apoptosis by tumor necrosis factor-related apoptosis-inducing ligand receptor-1 and -2." in: The Journal of biological chemistry, Vol. 276, Issue 5, pp. 3270-8, (2001) (PubMed).

Wang, Chun, Wong, Spencer, Lenardo: "Caspase-10 is an initiator caspase in death receptor signaling." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, Issue 24, pp. 13884-8, (2001) (PubMed).

Liao, Ozawa, Friess, Zimmermann, Takayama, Reed, Kleeff, Büchler: "The anti-apoptotic protein BAG-3 is overexpressed in pancreatic cancer and induced by heat stress in pancreatic cancer cell lines." in: FEBS letters, Vol. 503, Issue 2-3, pp. 151-7, (2001) (PubMed).

Antigendetails

Target: EnhancedTRAIL

Hintergrund: Induces apoptosis in a concentration range of 5-50 ng/mL in the presence of 1 μg/mL of TNF Ligands Enhancer .